相关实验视频

Updated: Jul 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

调查新型 thiazolyl-indazole衍生物作为SARS-CoV-2 M^Pro 抑制剂的支架

Justin Airas¹, Catherine A Bayas¹, Abdellah N'Ait Ousidi²

¹Department of Chemistry, University of Richmond, Gottwald Center for the Sciences, Richmond, VA, 23173, USA.

European journal of medicinal chemistry reports

|July 31, 2023

概括

新型 thiazolyl-indazole 衍生物显示出作为 SARS-CoV-2 主蛋白酶 (M^Pro) 抑制剂的潜力. 最有效的化合物表现出显著的蛋白酶抑制,这表明未来COVID-19治疗的有希望的支架.

科学领域:

药用化学医学化学
病毒学病毒学
药物发现药物发现药物发现

背景情况:

由SARS-CoV-2引起的COVID-19需要除了Remdesivir之外的新疗法.
SARS-CoV-2 主蛋白酶 (M^Pro) 对于病毒复制至关重要,也是药物开发的关键标.

研究的目的:

合成和评估新型的 thiazolyl-indazole衍生物作为SARS-CoV-2 M^Pro的抑制剂.
研究这些化合物与M^Pro的结合相互作用和亲和力.

主要方法:

通过异环化合成 thiazolyl-indazole 衍生物.
计算分析包括施罗丁格滑翔对接,AMBER分子动力学和MM-GBSA自由能量估计.
使用M^Pro生物化学试验进行实验验证.

主要成果:

分子模拟揭示了特定的结合相互作用,包括π-堆叠和S/π相互作用,与关键的M^Pro残留物.
一种化合物含有利醇部分,表现出强大的M^Pro抑制,IC₅₀为92.9μM.
这些发现突显了M^Pro抑制的结构-活性关系.

结论:

thiazolyl-indazole 衍生物,特别是那些具有 phenylthiazole 支架的衍生物,是开发新型 M^Pro 抑制剂的有希望的候选者.
这项研究为进一步优化这些化合物作为潜在的抗病毒剂对抗SARS-CoV-2提供了基础.

关键词:

具有约束力的测试.在 COVID-19 疫情中,新冠病毒新冠病毒新冠病毒.药物发现药物发现在 Indazole 中使用.抑制剂是一种抑制剂.MPro的MPro是什么意思MPro是什么意思分子动力学分子动力学蛋白质酶可以保护这就是SARS-CoV-2病毒.脚手架脚手架是一个脚手架.基板基板是一种基板.这是一种Thiazolylyl.提亚佐尔-英达尔 (Thiazolyl-indazole) 是一种一种

更多相关视频

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

Engineering Antiviral Agents via Surface Plasmon Resonance

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...